EUVIMEDOpdag EUVIMED
Fallbericht

COVID‐19 does not impact on outcome of myeloma patients infected while undergoing autologous stem cell transplantation

Lorenzo Masina, Nicola Bianchetti, Angela Passi, Chiara Bottelli, Samuele Bagnasco, Angelica Spolzino, Margherita Oberti, Marco Chiarini, Angelo Belotti, Simone Voltolini, Laura Faglioni, Giuseppe Rossi and 2 more

Hematological Oncology · 2023

DOI: 10.1002/hon.3127 ↗

At a glance

Fallbericht in Hematological Oncology, 2023. Written by Lorenzo Masina and 13 co-authors. Institution: Haematology, ASST Spedali Civili, Brescia, Italy. Major MEDLINE topics: Multiple Myeloma, Hematopoietic Stem Cell Transplantation, COVID-19. 10 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Here we report two cases of myeloma patients who became positive for SARS‐CoV‐2 infection during the acute phase of autologous stem cell transplant. Both patients were promptly treated with monoclonal antibodies and remdesivir, and, despite the profound neutropenia and lymphopenia, they did not develop respiratory failure and they remained paucisymptomatic during the entire period of aplasia. Neutrophil engraftment took place as expected and the patients were discharged quickly and did not experience adverse effects after discharge.

Subjects

MeSH terms (MEDLINE)

Multiple MyelomaHematopoietic Stem Cell TransplantationCOVID-19HumansSARS-CoV-2Transplantation, Autologous

Author keywords

COVID-19autologous stem cell transplantationmyelomaoutcome

Authors and institutions

  • Haematology, ASST Spedali Civili, Brescia, Italy.
  • Flow Cytometry Unit, Clinical Chemistry Laboratory, ASST Spedali Civili di Brescia, Brescia, Italy.
  • Oncology Department, Azienda Ospedaliera Carlo Poma, Mantova, Italy.

ORCID profiles: Chiara Cattaneo

Cite

APA

Masina, L., Bianchetti, N., Passi, A., Bottelli, C., Bagnasco, S., Spolzino, A., Oberti, M., Chiarini, M., Belotti, A., Voltolini, S., Faglioni, L., Rossi, G., Tucci, A., & Cattaneo, C. (2023). COVID‐19 does not impact on outcome of myeloma patients infected while undergoing autologous stem cell transplantation. Hematological Oncology. https://doi.org/10.1002/hon.3127

Vancouver

Masina L, Bianchetti N, Passi A, Bottelli C, Bagnasco S, Spolzino A, et al. COVID‐19 does not impact on outcome of myeloma patients infected while undergoing autologous stem cell transplantation. Hematological Oncology. 2023. doi:10.1002/hon.3127

BibTeX
@article{Masina2023,
  author = {Masina, Lorenzo and Bianchetti, Nicola and Passi, Angela and Bottelli, Chiara and Bagnasco, Samuele and Spolzino, Angelica and Oberti, Margherita and Chiarini, Marco and Belotti, Angelo and Voltolini, Simone and Faglioni, Laura and Rossi, Giuseppe and Tucci, Alessandra and Cattaneo, Chiara},
  title = {COVID‐19 does not impact on outcome of myeloma patients infected while undergoing autologous stem cell transplantation},
  journal = {Hematological Oncology},
  year = {2023},
  doi = {10.1002/hon.3127}
}
Start for free →